SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-004090
Filing Date
2024-03-27
Accepted
2024-03-27 16:29:16
Documents
89
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ampe-20231231x10k.htm   iXBRL 10-K 1984730
2 EX-31.1 ampe-20231231xex31d1.htm EX-31.1 8669
3 EX-31.2 ampe-20231231xex31d2.htm EX-31.2 8232
4 EX-32.1 ampe-20231231xex32d1.htm EX-32.1 7228
5 GRAPHIC ampe-20231231x10k004.jpg GRAPHIC 3040
  Complete submission text file 0001558370-24-004090.txt   8233433

Data Files

Seq Description Document Type Size
6 EX-101.SCH ampe-20231231.xsd EX-101.SCH 65713
7 EX-101.CAL ampe-20231231_cal.xml EX-101.CAL 57426
8 EX-101.DEF ampe-20231231_def.xml EX-101.DEF 205233
9 EX-101.LAB ampe-20231231_lab.xml EX-101.LAB 432091
10 EX-101.PRE ampe-20231231_pre.xml EX-101.PRE 378976
93 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20231231x10k_htm.xml XML 1440120
Mailing Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112
Business Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35182 | Film No.: 24791185
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)